Summary
YumYum infant formula is 100% original New Zealand-produced, manufactured by GMP Pharmaceuticals Ltd. on behalf of RC Young Holdings Ltd. As a subsidiary of RC Holdings in China, Shandong Lijian Biotechnology Co.
, Ltd. is responsible for sales and after-sales service of the brand in the Chinese market. In 2011, New Zealand Prime Minister John Key paid attention to the YumYum booth at a food expo, encouraging its export; in June 2012, with permission from New Zealand Trade and Enterprise and approval from China's Ministry of Commerce, YumYum successfully entered the Chinese market.
The product meets both international dairy standards and pharmaceutical standards. The milk source comes from New Zealand organic pastures and uses the NAIT animal identification and traceability system to ensure safety. GMP Pharmaceuticals holds TGA (Australia) and Medsafe (New Zealand) GMP certifications, as well as an FDA licence.
Its R&D team comprises professionals in health medicine, pharmacy and related fields. The brand is committed to providing high-quality, pure and safe infant formula for Chinese babies.
Commentary
This news presents two key opportunities for New Zealand SMEs. First, YumYum successfully entered the Chinese market through endorsement by the New Zealand Prime Minister and official trade channels, showing that high-level government support is an effective lever for accessing China. For SMEs in the dairy and related food sectors, it is worth partnering with New Zealand Trade and Enterprise to leverage the '100% Pure New Zealand' image to enhance brand trust.
Second, the dual certification (pharmaceutical-grade production standards) of GMP Pharmaceuticals provides a competitive advantage. SMEs can learn from this collaboration model with a large pharmaceutical company to open high-barrier markets through quality certifications. Risks to be aware of: China's infant formula market is strictly regulated.
The formula registration system introduced after 2018 requires overseas factories to undergo on-site inspections by Chinese customs, and consumers have high brand loyalty. It is recommended to pay attention to tariff preferences under the upgraded FTA with China, and to compliance requirements for cross-border e-commerce channels. From a consumption trend perspective, demand for premium formula among Chinese parents is still growing, but competition is fierce.
Brands need to highlight organic milk sources and full traceability. In conclusion, New Zealand brands still have room to grow given their natural advantages, but continuous investment in compliance and brand building is required.
Keywords: YumYum infant formula, New Zealand, infant formula, GMP Pharmaceuticals, entry into Chinese market, organic pasture, RC Holdings, Shandong Lijian, Prime Minister support
Source: Sogou Baike
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
